Brigida Anna Maiorano

30PUBLICATIONS
81CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 13, 2026
Correction: Parente et al. Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience. Diagnostics 2022, 12, 685.

|Aug 13, 2026
BRCA Testing in Prostate Cancer: A Histopathologist's Perspective.

|Jun 17, 2026
Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.

|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

|Mar 02, 2026
Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non-Muscle-Invasive Bladder Cancer Progress or Overreach?

Ashish M Kamat, Patrick J Hensley, Brigida A Maiorano

|Jan 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Orazio Caffo, Umberto Basso, Antonello Veccia

Pageof 5

Frequent Collaborators

7 joint publications

Evaristo Maiello

5 joint publications

Andrea Necchi

5 joint publications

Gennaro Cormio

5 joint publications

Mauro Francesco Pio Maiorano